Phillips Barclay A

Novavax, Inc.

SVP, Chief Financial Officer

Avg. Two Year Performance

213% Avg. Purchase Return    77% Compound
92% Avg. Sale Return    39% Compound

Holdings: 38.67K shares

Last Three Months: 23-Aug-24 -- 22-Nov-24

0 Net Amount
Buy:0--
Sell:0--

Sentiment

Insider Trading Sentiment: Hold

Company Sentiment

Biotechnology

Drugs

Insider Trading Sentiment:
Insider Trading Sentiment:
Insider Trading Sentiment:

Two Year Chart

23-Nov-22 -- 22-Nov-24

Price ($)

Sentiment

Company Sentiment

Most Recent Insider Transactions